Search Results - Elmi, Adily N.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The Role of MDM2 in Promoting Genome Stability versus Instability

    The Role of MDM2 in Promoting Genome Stability versus Instability by Saadatzadeh, M Reza, Elmi, Adily N, Pandya, Pankita H, Bijangi-Vishehsaraei, Khadijeh, Ding, Jixin, Stamatkin, Christopher W, Cohen-Gadol, Aaron A, Pollok, Karen E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Combined inhibition of Ref‐1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co‐culture models

    Combined inhibition of Ref‐1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co‐culture models by Caston, Rachel A., Shah, Fenil, Starcher, Colton L., Wireman, Randall, Babb, Olivia, Grimard, Michelle, McGeown, Jack, Armstrong, Lee, Tong, Yan, Pili, Roberto, Rupert, Joseph, Zimmers, Teresa A., Elmi, Adily N., Pollok, Karen E., Motea, Edward A., Kelley, Mark R., Fishel, Melissa L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report

    AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report by Elmi, Adily N., Heinemann, Scott D., van Besien, Koen, Gallogly, Molly M.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    AML-181 AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report

    AML-181 AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report by Elmi, Adily N., Heinemann, Scott D., van Besien, Koen, Gallogly, Molly M.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 3180: Preclinical validation of EZH2 as a therapeutic target in pediatric Ewing's sarcoma

    Abstract 3180: Preclinical validation of EZH2 as a therapeutic target in pediatric Ewing's sarcoma by Pandya, Pankita H., Bailey, Barbara, Elmi, Adily E., Bates, Heather R., Hemenway, Courtney N., Sinn, Anthony L., Bijangi-Vishehsaraei, Khadijeh, Saadatzadeh, M. Reza, Shannon, Harlan E., Ding, Jixin, Marshall, Mark S., Ferguson, Michael J., Cheng, Lijun, Li, Lang, Murray, Mary E., Renbarger, Jamie L., Pollok, Karen E.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma

    Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma by Pandya, Pankita H., Cheng, Lijun, Saadatzadeh, M. Reza, Bijangi-Vishehsaraei, Khadijeh, Tang, Shan, Sinn, Anthony L., Trowbridge, Melissa A., Coy, Kathryn L., Bailey, Barbara J., Young, Courtney N., Ding, Jixin, Dobrota, Erika A., Dyer, Savannah, Elmi, Adily, Thompson, Quinton, Barghi, Farinaz, Shultz, Jeremiah, Albright, Eric A., Shannon, Harlan E., Murray, Mary E., Marshall, Mark S., Ferguson, Michael J., Bertrand, Todd E., Wurtz, L. Daniel, Batra, Sandeep, Li, Lang, Renbarger, Jamie L., Pollok, Karen E.

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: